DiscGenics Raises $50 Million in Series C Funding
Salt Lake City, UT – August 25, 2020 – DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative...